|
Volumn 758, Issue 2, 2001, Pages 129-135
|
High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction
a a a a a |
Author keywords
Amprenavir; Indinavir; Nelfinavir; Nevirapine; Ritonavir; Saquinavir
|
Indexed keywords
ACETIC ACID;
BIOASSAY;
DRUG DOSAGE;
PATIENT MONITORING;
SOLVENTS;
HUMAN PLASMA;
BIOMEDICAL ENGINEERING;
AMPRENAVIR;
INDINAVIR;
NELFINAVIR;
NEVIRAPINE;
PROTEINASE INHIBITOR;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
ACCURACY;
ARTICLE;
BLOOD LEVEL;
COMPARATIVE STUDY;
DRUG DETERMINATION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN IMMUNODEFICIENCY VIRUS;
LIQUID LIQUID EXTRACTION;
PRIORITY JOURNAL;
SPECTRAL SENSITIVITY;
CALIBRATION;
CARBAMATES;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
HIV PROTEASE INHIBITORS;
HUMANS;
INDINAVIR;
NELFINAVIR;
NEVIRAPINE;
REFERENCE STANDARDS;
REPRODUCIBILITY OF RESULTS;
REVERSE TRANSCRIPTASE INHIBITORS;
RITONAVIR;
SAQUINAVIR;
SENSITIVITY AND SPECIFICITY;
SULFONAMIDES;
|
EID: 0035879916
PISSN: 13872273
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-4347(01)00117-7 Document Type: Article |
Times cited : (75)
|
References (11)
|